Raucoules-Aimé M, Lugrin D, Boussofara M, Gastaud P, Dolisi C, Grimaud D
Department of Ophthalmology, Hôpital Saint-Roch, Nice, France.
Br J Anaesth. 1994 Oct;73(4):443-9. doi: 10.1093/bja/73.4.443.
We have compared intraoperative glycaemic control, insulin requirements and metabolic and endocrine variables in 40 non-insulin-dependent diabetic patients (NIDDM) and 40 insulin-dependent diabetic patients (IDDM) undergoing general anaesthesia for elective procedures. Two i.v. insulin regimens were used: continuous i.v. infusion (group A: 1.25 u.h-1) and repeated i.v. boluses (10 u./2 h). Blood concentrations of glucose were measured every 15 min from just before induction of anaesthesia until 2 h after surgery. Plasma lactate and pyruvate concentrations, ketone bodies, C-peptide and counter-regulatory hormones were also measured. Glycaemia did not differ significantly in the two types of diabetes, regardless of the insulin therapy used. The amounts of insulin administered were similar in NIDDM and IDDM. There was no significant difference for other metabolic variables. Plasma concentrations of growth hormone (GH) increased significantly during surgery, especially in IDDM patients, but this change did not alter intraoperative glycaemic control. We conclude that mean glycaemic control, insulin requirements and development of ketone bodies in NIDDM and IDDM patients did not differ during the operative period, regardless of the insulin regimen used. Therefore, during the operative period, it is not necessary to modify the insulin regimen according to the type of diabetes. The consequences of increased plasma GH concentrations on glycaemic control in IDDM patients after operation are unknown.
我们比较了40例接受择期手术全身麻醉的非胰岛素依赖型糖尿病患者(NIDDM)和40例胰岛素依赖型糖尿病患者(IDDM)的术中血糖控制、胰岛素需求量以及代谢和内分泌变量。使用了两种静脉胰岛素治疗方案:持续静脉输注(A组:1.25 u·h⁻¹)和重复静脉推注(10 u/2 h)。从麻醉诱导前直至术后2小时,每隔15分钟测量血糖浓度。还测量了血浆乳酸和丙酮酸浓度、酮体、C肽和反调节激素。无论使用何种胰岛素治疗,两种类型糖尿病患者的血糖水平均无显著差异。NIDDM和IDDM患者的胰岛素给药量相似。其他代谢变量也无显著差异。手术期间血浆生长激素(GH)浓度显著升高,尤其是在IDDM患者中,但这种变化并未改变术中血糖控制。我们得出结论,无论使用何种胰岛素方案,NIDDM和IDDM患者在手术期间的平均血糖控制、胰岛素需求量和酮体生成均无差异。因此,在手术期间,无需根据糖尿病类型调整胰岛素方案。术后IDDM患者血浆GH浓度升高对血糖控制的影响尚不清楚。